Healthcare >> CEO Interviews >> November 15, 2010
Dr. Ray Salemme holds a B.A. in molecular biophysics from Yale University and a Ph.D. in chemistry from the University of California, San Diego. Following a successful academic career, he moved to work in the biotechnology industry in 1982. He subsequently worked for several years at DuPont Central Research, DuPont Merck Pharmaceuticals and Sterling Winthrop Pharmaceuticals. In 1993 Dr. Salemme founded 3-Dimensional Pharmaceuticals (3DP), an advanced drug discovery company integrating combinatorial chemistry, structure-based drug design, high throughput screening and cheminformatics, within a comprehensive IT infrastructure. 3DP was acquired by Johnson & Johnson in 2003. Dr. Salemme joined Redpoint Bio Corp. as CEO in 2004. Profile
TWST: Would you begin with a brief historical sketch of the company and a picture of the things you are doing at the present time?
Dr. Salemme: Yes, thank you very much. I joined the company about six